Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) ("Biodexa" or "Company"), a clinical stage biopharmaceutical company developing a clinical stage biopharmaceutical company developing innovative products ...
BENGALURU, India, Oct. 27, 2025 /PRNewswire/ -- Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its ...
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), reports that that its newly upgraded biologics facility (Unit 3) in Bangalore, India, will be ...
Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “Company”), a clinical stage biopharmaceutical company developing a clinical stage biopharmaceutical company developing innovative products ...
PRINCETON, N.J. & BANGALORE, India--Bristol-Myers Squibb (NYSE:BMY) and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results